Marc Beer’s Triumphant Fight Against Rare and Women’s Health Disorders

Over the last century, the medical sector has seen a lot of advancements thanks to breakthroughs in the biotechnology and pharmaceutical sectors. Despite this, some areas like women’s health complications and rare disorders were left behind. Most of the biopharma companies have not had an incentive to pursue this field for one reason or another. In light of this, Marc Beer, who at the time was an executive in the sector responsible for development and commercialization medicines, decide to pursue this course. He jumped into entrepreneurship in 2000 and has had a lot of success to date.


Tackling Rare Disorders


Reliable statistics indicate that 7000 rare disorders affect more than 350 million people globally. The number of people affected by these rare disorders is expected to increase as the global population rises. In 2000, Marc Beer took the initiative to fight these rare disorders when he founded ViaCell. This startup focused on developing a variety of treatments for rare conditions by collecting and preserving blood stem cells from the umbilical cord.


Under the leadership of Marc, this company grew to become a biotech icon with more than 300 employees by 2005. This same year the company went public, and two years later, it was bought by PerkinElmer for $300 million. It was the success that ViaCell had that put Marc on the map as an outstanding biopharma sector entrepreneur.


Making Life Liveable For Millions of Women Globally


Marc Beer’s next entrepreneurial venture was Renovia, which is based in Boston. He founded this company together with Ray Iglesias and Yolanda Lorie in 2016. Renovia focuses on finding therapeutic and diagnostic solutions to women’s health problems. The inspiration behind the founding of the company was to address pelvic floor disorders.


Pelvic floor disorders include fecal incontinence, urinal incontinence, and pelvic organ prolapse. This condition is brought about by interstitial cystitis, chronic pelvic inflammatory disease, digestive diseases, endometriosis, and uterine fibroids. In the United States, it is estimated that 25% of women suffer from this condition.


This biopharma entrepreneur hopes that the progress his company makes will help millions of women across the globe live a happy life. In April 2018, the FDA approved a therapeutic and diagnostic device created by Renovia to be the first diagnostic option for women suffering from pelvic floor disorders. With the first edition of the device in the market, Marc has set his company to improve the device to be more comfortable to use.


About Marc Beer


This entrepreneur is the current CEO and Chairman of Renovia. He has been working in the biopharma sector ever since 1987 when he graduated from Miami University, where he was pursuing a BS in Business. Thanks to his entrepreneurial ventures, the biotechnology and pharmaceutical sectors have now given some attention to previously neglected areas. This is a move that will save lives across the world in millions. Learn more:


Apart from business, Marc Beer also commits some of his time towards the betterment of society. He has donated a significant amount of money towards charity. He has also served and continues to serve on various boards like the Miami University Business Advisory Council.

Follow Marc Beer on Facebook